Edge
StocktwitsEarnings

Official STOCKTWITS Representative

$XERS Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.18 down -1700.00% YoY
• Reported revenue of $92.1M up 28.74% YoY
• Xeris Biopharma Holdings tightened its full-year 2026 total revenue guidance to a range of $385 million to $390 million, reflecting the company's confidence in its portfolio and business trajectory.Price since post
Advertisement|Remove ads.